Comparison of Urinary Flow Study
Launched by WAKE FOREST UNIVERSITY HEALTH SCIENCES · Apr 4, 2025
Trial Information
Current as of June 26, 2025
Not yet recruiting
Keywords
ClinConnect Summary
This clinical trial is studying how quickly urine flows when using two different types of female catheters. The study will compare the "14 Fr Two Eyelet Coloplast Female SpeediCath Urinary Catheter" with the "14 Fr Coloplast Micro Zone Luja Female Catheter." The goal is to see which catheter works better for women who use intermittent catheters to empty their bladders.
To participate, you need to be a woman aged 18 or older who has been using intermittent catheters for at least a month. You shouldn't have any serious urinary tract issues, allergies to the catheters, or recent surgeries, and you should not be pregnant or breastfeeding. If you decide to join, you'll attend one visit that lasts about an hour, where you'll use the catheters, and then you'll have a follow-up phone call about a week later. This study is not yet recruiting participants, but it may be a good opportunity for women looking for ways to improve their bladder care.
Gender
FEMALE
Eligibility criteria
- Inclusion Criteria:
- • Female
- • Regular use of intermittent catheters to empty bladder, for at least 1 month before enrolment
- • Age 18 years or older
- • Required to adhere to the intervention procedure and not participate in any other clinical studies throughout the duration of this study
- Exclusion Criteria:
- • Severe urinary tract abnormalities (e.g. excessive production of urinary mucus/sediments/debris)
- • Hypersensitive to the ingredients in the catheters being tested
- • Recent surgery, within 3 months
- • Currently being treated for urinary tract infection
- • Being pregnant or breastfeeding
- • Non-English speaking
About Wake Forest University Health Sciences
Wake Forest University Health Sciences is a leading academic research institution dedicated to advancing healthcare through innovative clinical trials and translational research. With a strong emphasis on multidisciplinary collaboration, the organization leverages its extensive expertise in medical research, patient care, and education to develop and evaluate new therapies and interventions. Committed to improving patient outcomes and public health, Wake Forest University Health Sciences fosters a dynamic environment for scientific inquiry, engaging in a wide range of clinical studies that address pressing health challenges. Through its rigorous methodologies and ethical standards, the institution aims to contribute significantly to the medical field and enhance the quality of life for diverse populations.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Charlotte, North Carolina, United States
Patients applied
Trial Officials
Michael Kennelly, MD
Principal Investigator
Wake Forest University Health Sciences
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported